Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -68,524 | -42,127 | -8,840 | -26,887 | -21,282 |
| Depreciation Amortization | 36 | 12 | -3 | 44 | 13 |
| Accounts receivable | -1,348 | 582 | 351 | 3,614 | 3,651 |
| Accounts payable and accrued liabilities | -245 | 1,175 | 1,091 | 760 | -246 |
| Other Working Capital | 3,961 | 4,508 | 2,610 | -936 | -3,322 |
| Other Operating Activity | 50,705 | 23,403 | -617 | -7,661 | -2,427 |
| Operating Cash Flow | $-15,415 | $-12,447 | $-5,408 | $-31,066 | $-23,613 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -12,843 | -1,034 | 8,252 | -757 | -10,935 |
| PPE Investments | N/A | N/A | N/A | -7 | -7 |
| Investing Cash Flow | $-12,843 | $-1,034 | $8,252 | $-764 | $-10,942 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,000 | 5,000 | N/A | 5,000 | 5,000 |
| Common Stock Issued | 24,516 | 24,245 | 15,471 | 15,407 | 15,406 |
| Other Financing Activity | 0 | 0 | 0 | -115 | -115 |
| Financing Cash Flow | $29,516 | $29,245 | $15,471 | $20,292 | $20,291 |
| Beginning Cash Position | 15,096 | 15,096 | 15,096 | 26,634 | 26,634 |
| End Cash Position | 16,354 | 30,860 | 33,411 | 15,096 | 12,370 |
| Net Cash Flow | $1,258 | $15,764 | $18,315 | $-11,538 | $-14,264 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,415 | -12,447 | -5,408 | -31,066 | -23,613 |
| Capital Expenditure | N/A | N/A | N/A | -7 | -7 |
| Free Cash Flow | -15,415 | -12,447 | -5,408 | -31,073 | -23,620 |